{"transactions":[{"id":716469,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-07-06T22:50:47.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":2301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2026 totals no more than $400,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of Restricted Stock Unit award on July 1, 2026 to the reporting person under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier; however, the reporting person has elected to defer delivery of such shares until the earlier to occur of the fifth anniversary of the vesting date, the 30th day following the reporting person's Separation from Service from the Company or the date of a Change in Control of the Company, both as defined in Treasury Regulation Section 1.409A. These Restricted Stock Units are vested as to 0 shares on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Grant of Restricted Stock Unit award on July 1, 2026 to the reporting person under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier; however, the reporting person has elected to defer delivery of such shares until the earlier to occur of the fifth anniversary of the vesting date, the 30th day following the reporting person's Separation from Service from the Company or the date of a Change in Control of the Company, both as defined in Treasury Regulation Section 1.409A. These Restricted Stock Units are vested as to 0 shares on July 1, 2026."}],"balance_after":9451,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2301},"source":{"system":"sec-edgar","filing":"0000874015-26-000232","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000232/edgardoc.xml","form_type":"4"}},{"id":716468,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-07-06T22:50:47.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2026 totals no more than $400,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant on July 1, 2026 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant on July 1, 2026 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2026."}],"balance_after":5369,"derivative":{"exercise_price":79.19,"exercise_date":"2027-07-01","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0000874015-26-000232","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000232/edgardoc.xml","form_type":"4"}},{"id":739325,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-13T01:07:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043005","document":"wk-form4_1781312832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043005/wk-form4_1781312832.xml","form_type":"4"}},{"id":739324,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T01:07:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":19798,"source":{"system":"sec-edgar","filing":"0001628280-26-043005","document":"wk-form4_1781312832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026043005/wk-form4_1781312832.xml","form_type":"4"}},{"id":936248,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-01-21T01:21:43.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":false,"shares":1930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in three equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in three equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":7150,"derivative":{"exercise_price":0,"exercise_date":"2026-01-15","underlying":"Common Stock","underlying_shares":1930},"source":{"system":"sec-edgar","filing":"0000874015-26-000073","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000073/edgardoc.xml","form_type":"4"}},{"id":936247,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T01:21:43.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":true,"shares":1930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":7940,"source":{"system":"sec-edgar","filing":"0000874015-26-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401526000073/edgardoc.xml","form_type":"4"}},{"id":1085976,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-17T20:54:38.000Z","date":"2025-07-15","kind":"exercise","planned":false,"acquired":false,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":9080,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4079},"source":{"system":"sec-edgar","filing":"0000874015-25-000161","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000161/edgardoc.xml","form_type":"4"}},{"id":1085975,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-17T20:54:38.000Z","date":"2025-07-15","kind":"exercise","planned":false,"acquired":true,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":6010,"source":{"system":"sec-edgar","filing":"0000874015-25-000161","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000161/edgardoc.xml","form_type":"4"}},{"id":1096734,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-02T20:53:41.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":5220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2025 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant on July 1, 2025 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Grant on July 1, 2025 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2025."}],"balance_after":13159,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5220},"source":{"system":"sec-edgar","filing":"0000874015-25-000144","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000144/edgardoc.xml","form_type":"4"}},{"id":1096733,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-07-02T20:53:41.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":11518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2025 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant on July 1, 2025 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant on July 1, 2025 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2025."}],"balance_after":11518,"derivative":{"exercise_price":39.94,"exercise_date":"2026-07-01","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":11518},"source":{"system":"sec-edgar","filing":"0000874015-25-000144","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000144/edgardoc.xml","form_type":"4"}},{"id":1111149,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:17:55.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000083","document":"wk-form4_1749845868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000083/wk-form4_1749845868.xml","form_type":"4"}},{"id":1111148,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:17:55.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":13393,"source":{"system":"sec-edgar","filing":"0001396814-25-000083","document":"wk-form4_1749845868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000083/wk-form4_1749845868.xml","form_type":"4"}},{"id":1301010,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-01-18T00:41:44.000Z","date":"2025-01-15","kind":"exercise","planned":false,"acquired":false,"shares":1931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in three equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in three equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":7939,"derivative":{"exercise_price":0,"exercise_date":"2025-01-15","underlying":"Common Stock","underlying_shares":1931},"source":{"system":"sec-edgar","filing":"0000874015-25-000066","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000066/edgardoc.xml","form_type":"4"}},{"id":1301009,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-18T00:41:44.000Z","date":"2025-01-15","kind":"exercise","planned":false,"acquired":true,"shares":1931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award."}],"balance_after":1931,"source":{"system":"sec-edgar","filing":"0000874015-25-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401525000066/edgardoc.xml","form_type":"4"}},{"id":1433412,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:35:09.000Z","date":"2024-08-14","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":12.9,"value":25800.0,"ownership":{"direct":true},"balance_after":7230,"source":{"system":"sec-edgar","filing":"0001396814-24-000114","document":"wk-form4_1723667702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000114/wk-form4_1723667702.xml","form_type":"4"}},{"id":1461395,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-03T19:13:00.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2024 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant on July 1, 2024 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Grant on July 1, 2024 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2024."}],"balance_after":9870,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4079},"source":{"system":"sec-edgar","filing":"0000874015-24-000169","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401524000169/edgardoc.xml","form_type":"4/A","original_submission_date":"2024-07-03"}},{"id":1461394,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-07-03T18:48:52.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":10111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Company's Non-Employee Director Compensation Policy, these grants were adjusted downward such that the non-employee Director's annual equity compensation in 2024 totals no more than $450,000 based on the aggregate grant date fair value as determined in accordance with FASB Topic ASC 718."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant on July 1, 2024 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant on July 1, 2024 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2024."}],"balance_after":10111,"derivative":{"exercise_price":47.11,"exercise_date":"2025-07-01","expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":10111},"source":{"system":"sec-edgar","filing":"0000874015-24-000167","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401524000167/edgardoc.xml","form_type":"4"}},{"id":1480284,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T22:13:59.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":12179,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12179,"derivative":{"exercise_price":28.68,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":12179},"source":{"system":"sec-edgar","filing":"0001396814-24-000080","document":"wk-form4_1718316831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000080/wk-form4_1718316831.xml","form_type":"4"}},{"id":1480283,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T22:13:59.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":5230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":5230,"source":{"system":"sec-edgar","filing":"0001396814-24-000080","document":"wk-form4_1718316831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000080/wk-form4_1718316831.xml","form_type":"4"}},{"id":1678516,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-01-18T01:50:33.000Z","date":"2024-01-15","kind":"grant","planned":false,"acquired":true,"shares":5791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant on January 15, 2024 to reporting person of Restricted Stock Unit Award under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in three equal annual installments, the first installment vesting on January 15, 2025. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2027. The RSU is vested as to 0 shares on January 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant on January 15, 2024 to reporting person of Restricted Stock Unit Award under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in three equal annual installments, the first installment vesting on January 15, 2025. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2027. The RSU is vested as to 0 shares on January 15, 2024."}],"balance_after":5791,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5791},"source":{"system":"sec-edgar","filing":"0000874015-24-000057","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401524000057/edgardoc.xml","form_type":"4"}},{"id":1708162,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-12-18T21:58:07.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":12356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of 12/14/2023 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended & Restated 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in three equal annual installments, the first installment vesting on 12/14/2024. The option shall be fully vested and exercisable on 12/14/2026. The stock option was exercisable as to 0 shares on 12/14/2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Grant of 12/14/2023 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended & Restated 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in three equal annual installments, the first installment vesting on 12/14/2024. The option shall be fully vested and exercisable on 12/14/2026. The stock option was exercisable as to 0 shares on 12/14/2023."}],"balance_after":12356,"derivative":{"exercise_price":49.82,"exercise_date":"2024-12-14","expiration_date":"2033-12-14","underlying":"Common Stock","underlying_shares":12356},"source":{"system":"sec-edgar","filing":"0000874015-23-000230","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401523000230/edgardoc.xml","form_type":"4"}},{"id":1761703,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-11T20:46:54.000Z","date":"2023-10-06","kind":"grant","planned":false,"acquired":true,"shares":30967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 36 equal successive monthly installments over the 36-month period following the date of grant, subject to the reporting person's continued service as a director."}],"balance_after":30967,"derivative":{"exercise_price":29.8,"expiration_date":"2033-10-06","underlying":"Common Stock","underlying_shares":30967},"source":{"system":"sec-edgar","filing":"0001396814-23-000072","document":"wk-form4_1697057204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681423000072/wk-form4_1697057204.xml","form_type":"4"}},{"id":2912685,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Restricted Stock Units","published_at":"2021-01-09T00:31:12.000Z","date":"2021-01-06","kind":"exercise","acquired":false,"shares":2722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":8167,"derivative":{"underlying":"Common Stock","underlying_shares":2722},"source":{"system":"sec-edgar","filing":"0001209191-21-002836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002836/doc4.xml","form_type":"4"}},{"id":2912684,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2021-01-09T00:31:12.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":1120,"price":53.34,"value":59740.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":8059,"source":{"system":"sec-edgar","filing":"0001209191-21-002836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002836/doc4.xml","form_type":"4"}},{"id":2912683,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2021-01-09T00:31:12.000Z","date":"2021-01-06","kind":"exercise","acquired":true,"shares":2722,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":9179,"source":{"system":"sec-edgar","filing":"0001209191-21-002836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002836/doc4.xml","form_type":"4"}},{"id":3004407,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Restricted Stock Units","published_at":"2020-10-19T21:27:20.000Z","date":"2020-10-15","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-20-055317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120055317/doc4.xml","form_type":"4"}},{"id":3004406,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2020-10-19T21:27:20.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":1247,"price":42.56,"value":53072.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":6457,"source":{"system":"sec-edgar","filing":"0001209191-20-055317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120055317/doc4.xml","form_type":"4"}},{"id":3004405,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2020-10-19T21:27:20.000Z","date":"2020-10-15","kind":"exercise","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":7704,"source":{"system":"sec-edgar","filing":"0001209191-20-055317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120055317/doc4.xml","form_type":"4"}},{"id":3007815,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-13T15:45:31.000Z","date":"2020-10-12","kind":"disposition_to_issuer","acquired":false,"shares":26400,"price":2.01,"value":53064.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which provided for vesting of the shares on April 13, 2021, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $53,064.00, representing the difference between the exercise price of the option and the acquisition price of $18.15."}],"balance_after":0,"derivative":{"exercise_price":16.14,"expiration_date":"2030-04-12","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001209191-20-054611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120054611/doc4.xml","form_type":"4"}},{"id":3085856,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-09T22:26:43.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":14750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the 59,042 shares originally subject to the Stock Option vested and became exercisable on April 29, 2020. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":44292,"derivative":{"exercise_price":25.12,"expiration_date":"2029-04-29","underlying":"Common Stock","underlying_shares":14750},"source":{"system":"sec-edgar","filing":"0001209191-20-042022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120042022/doc4.xml","form_type":"4"}},{"id":3085855,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-09T22:26:43.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the 40,000 shares originally subject to the Stock Option vested and became exercisable on October 15, 2019. The remaining shares vest and become excercisable thereafter in 36 equal monthly installments."}],"balance_after":25000,"derivative":{"exercise_price":21.28,"expiration_date":"2028-10-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-042022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120042022/doc4.xml","form_type":"4"}},{"id":3085854,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-09T22:26:43.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 600,000 shares originally subject to the Stock Option vested and became exercisable on April 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments"}],"balance_after":570000,"derivative":{"exercise_price":19.98,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-042022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120042022/doc4.xml","form_type":"4"}},{"id":3085853,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2020-07-09T22:26:43.000Z","date":"2020-07-07","kind":"sale","acquired":false,"shares":11100,"price":56.5382,"value":627574.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to an amended Rule 10b5-1 stock sale plan dated May 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.395 to $56.685, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5204,"source":{"system":"sec-edgar","filing":"0001209191-20-042022","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120042022/doc4.xml","form_type":"4"}},{"id":3085852,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2020-07-09T22:26:43.000Z","date":"2020-07-07","kind":"sale","acquired":false,"shares":16150,"price":56.0503,"value":905212.345,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to an amended Rule 10b5-1 stock sale plan dated May 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.39 to $56.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":16304,"source":{"system":"sec-edgar","filing":"0001209191-20-042022","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120042022/doc4.xml","form_type":"4"}},{"id":3085851,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2020-07-09T22:26:43.000Z","date":"2020-07-07","kind":"exercise","acquired":true,"shares":14750,"price":25.12,"value":370520.0,"ownership":{"direct":true},"balance_after":32454,"source":{"system":"sec-edgar","filing":"0001209191-20-042022","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120042022/doc4.xml","form_type":"4"}},{"id":3085850,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2020-07-09T22:26:43.000Z","date":"2020-07-07","kind":"exercise","acquired":true,"shares":5000,"price":21.28,"value":106400.0,"ownership":{"direct":true},"balance_after":17704,"source":{"system":"sec-edgar","filing":"0001209191-20-042022","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120042022/doc4.xml","form_type":"4"}},{"id":3085849,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2020-07-09T22:26:43.000Z","date":"2020-07-07","kind":"exercise","acquired":true,"shares":7500,"price":19.98,"value":149850.0,"ownership":{"direct":true},"balance_after":12704,"source":{"system":"sec-edgar","filing":"0001209191-20-042022","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120042022/doc4.xml","form_type":"4"}},{"id":3165652,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Restricted Stock Units","published_at":"2020-05-01T22:00:15.000Z","date":"2020-04-29","kind":"exercise","acquired":false,"shares":4206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."}],"balance_after":12621,"derivative":{"underlying":"Common Stock","underlying_shares":4206},"source":{"system":"sec-edgar","filing":"0001209191-20-026618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120026618/doc4.xml","form_type":"4"}},{"id":3165651,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2020-05-01T22:00:15.000Z","date":"2020-04-30","kind":"sale","acquired":false,"shares":1501,"price":49.21,"value":73864.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":5204,"source":{"system":"sec-edgar","filing":"0001209191-20-026618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120026618/doc4.xml","form_type":"4"}},{"id":3165650,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2020-05-01T22:00:15.000Z","date":"2020-04-29","kind":"exercise","acquired":true,"shares":4206,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."}],"balance_after":6705,"source":{"system":"sec-edgar","filing":"0001209191-20-026618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120026618/doc4.xml","form_type":"4"}},{"id":3176207,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-15T17:13:44.000Z","date":"2020-04-13","kind":"grant","acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the 12-month anniversary of the date of grant."}],"balance_after":26400,"derivative":{"exercise_price":16.14,"expiration_date":"2030-04-12","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001209191-20-024503","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120024503/doc4.xml","form_type":"4"}},{"id":3315482,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Restricted Stock Units","published_at":"2020-01-08T23:08:42.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":10889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":10889,"derivative":{"underlying":"Common Stock","underlying_shares":10889},"source":{"system":"sec-edgar","filing":"0001209191-20-002604","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120002604/doc4.xml","form_type":"4"}},{"id":3315481,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-01-08T23:08:42.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":39516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on January 6, 2021. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":39516,"derivative":{"exercise_price":42.81,"expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":39516},"source":{"system":"sec-edgar","filing":"0001209191-20-002604","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120002604/doc4.xml","form_type":"4"}},{"id":3342539,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-13T22:35:50.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":72979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the 400,000 shares originally subject to the stock option vested and became exercisable on March 29, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":312500,"derivative":{"exercise_price":35.86,"expiration_date":"2027-03-28","underlying":"Common Stock","underlying_shares":72979},"source":{"system":"sec-edgar","filing":"0001209191-19-060476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060476/doc4.xml","form_type":"4"}},{"id":3342538,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-13T22:35:50.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the 40,000 shares originally subject to the Stock Option vested and became exercisable on October 15, 2019. The remaining shares vest and become excercisable thereafter in 36 equal monthly installments."}],"balance_after":30000,"derivative":{"exercise_price":21.28,"expiration_date":"2028-10-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-060476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060476/doc4.xml","form_type":"4"}},{"id":3342537,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-13T22:35:50.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the 600,000 shares originally subject to the Stock Option vested and became exercisable on April 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments"}],"balance_after":577500,"derivative":{"exercise_price":19.98,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-19-060476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060476/doc4.xml","form_type":"4"}},{"id":3342536,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-12-13T22:35:50.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":5032,"price":43.735,"value":220074.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.67 to $43.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":2499,"source":{"system":"sec-edgar","filing":"0001209191-19-060476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060476/doc4.xml","form_type":"4"}},{"id":3342535,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-12-13T22:35:50.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":100447,"price":44.493,"value":4469188.371,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.755 to $44.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7531,"source":{"system":"sec-edgar","filing":"0001209191-19-060476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060476/doc4.xml","form_type":"4"}},{"id":3342534,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-12-13T22:35:50.000Z","date":"2019-12-12","kind":"exercise","acquired":true,"shares":72979,"price":35.86,"value":2617026.94,"ownership":{"direct":true},"balance_after":107978,"source":{"system":"sec-edgar","filing":"0001209191-19-060476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060476/doc4.xml","form_type":"4"}},{"id":3342533,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-12-13T22:35:50.000Z","date":"2019-12-12","kind":"exercise","acquired":true,"shares":10000,"price":21.28,"value":212800.0,"ownership":{"direct":true},"balance_after":34999,"source":{"system":"sec-edgar","filing":"0001209191-19-060476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060476/doc4.xml","form_type":"4"}},{"id":3342532,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-12-13T22:35:50.000Z","date":"2019-12-12","kind":"exercise","acquired":true,"shares":22500,"price":19.98,"value":449550.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 876 shares of the Issuer's common stock acquired by the reporting person on November 15, 2017 pursuant to an employee stock purchase program."}],"balance_after":24999,"source":{"system":"sec-edgar","filing":"0001209191-19-060476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060476/doc4.xml","form_type":"4"}},{"id":3345673,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-11T23:30:43.000Z","date":"2019-12-09","kind":"exercise","acquired":false,"shares":14521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 400,000 shares originally subject to the stock option vested and became exercisable on March 29, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":385479,"derivative":{"exercise_price":35.86,"expiration_date":"2027-03-28","underlying":"Common Stock","underlying_shares":14521},"source":{"system":"sec-edgar","filing":"0001209191-19-060101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060101/doc4.xml","form_type":"4"}},{"id":3345672,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-12-11T23:30:43.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":3502,"price":50.0531,"value":175285.9562,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1623,"source":{"system":"sec-edgar","filing":"0001209191-19-060101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060101/doc4.xml","form_type":"4"}},{"id":3345671,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-12-11T23:30:43.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":11019,"price":50.595,"value":557506.305,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.17 to $51.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5125,"source":{"system":"sec-edgar","filing":"0001209191-19-060101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060101/doc4.xml","form_type":"4"}},{"id":3345670,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-12-11T23:30:43.000Z","date":"2019-12-09","kind":"exercise","acquired":true,"shares":14521,"price":35.86,"value":520723.06,"ownership":{"direct":true},"balance_after":16144,"source":{"system":"sec-edgar","filing":"0001209191-19-060101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060101/doc4.xml","form_type":"4"}},{"id":3392377,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Restricted Stock Units","published_at":"2019-10-17T22:25:40.000Z","date":"2019-10-15","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-19-053493","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119053493/doc4.xml","form_type":"4"}},{"id":3392376,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-10-17T22:25:40.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":877,"price":39.65,"value":34773.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":1623,"source":{"system":"sec-edgar","filing":"0001209191-19-053493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119053493/doc4.xml","form_type":"4"}},{"id":3392375,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Common Stock","published_at":"2019-10-17T22:25:40.000Z","date":"2019-10-15","kind":"exercise","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-19-053493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119053493/doc4.xml","form_type":"4"}},{"id":3407564,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-23T17:12:12.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":53000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest over a four year period in equal annual installments beginning on September 20, 2019."}],"balance_after":53000,"derivative":{"exercise_price":22.46,"expiration_date":"2029-09-19","underlying":"Common Stock","underlying_shares":53000},"source":{"system":"sec-edgar","filing":"0001209191-19-050475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919119050475/doc4.xml","form_type":"4"}},{"id":3544601,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Restricted Stock Units","published_at":"2019-05-01T22:01:51.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":16827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."}],"balance_after":16827,"derivative":{"underlying":"Common Stock","underlying_shares":16827},"source":{"system":"sec-edgar","filing":"0001209191-19-026847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119026847/doc4.xml","form_type":"4"}},{"id":3544600,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-05-01T22:01:51.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":59042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 29, 2020. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":59042,"derivative":{"exercise_price":25.12,"expiration_date":"2029-04-29","underlying":"Common Stock","underlying_shares":59042},"source":{"system":"sec-edgar","filing":"0001209191-19-026847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119026847/doc4.xml","form_type":"4"}},{"id":3784417,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CCO"}}],"security":"Restricted Stock Units","published_at":"2018-10-24T20:25:27.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning October 15, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning October 15, 2019."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-027361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000089924318027361/doc4.xml","form_type":"4"}},{"id":3784416,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CCO"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-24T20:25:27.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on October 15, 2019. The remaining shares vest and become excercisable thereafter in 36 equal monthly installments."}],"balance_after":40000,"derivative":{"exercise_price":21.28,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-18-027361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000089924318027361/doc4.xml","form_type":"4"}},{"id":3959497,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CCO"}}],"security":"Stock Option (right to buy)","published_at":"2018-04-20T22:35:42.000Z","date":"2018-04-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on April 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":60000,"derivative":{"exercise_price":19.98,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-18-000657","document":"form4-04202018_030428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000657/form4-04202018_030428.xml","form_type":"4"}},{"id":4213864,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CCO"}}],"security":"Stock Option (right to buy)","published_at":"2017-09-08T22:14:34.000Z","date":"2017-09-07","kind":"grant","acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on September 7, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":93750,"derivative":{"exercise_price":35.8,"expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001415889-17-001471","document":"form4-09082017_030923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001471/form4-09082017_030923.xml","form_type":"4"}},{"id":4367236,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":32407,"kind":"person","name":"YANG MICHAEL J.","position":1,"cik":"0001702283","reported_name":"YANG MICHAEL J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CCO"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-31T21:03:23.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on March 29, 2018.  The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":400000,"derivative":{"exercise_price":35.86,"expiration_date":"2027-03-28","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001415889-17-000528","document":"form4-03312017_020314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000528/form4-03312017_020314.xml","form_type":"4"}}]}